{"id":414,"date":"2026-07-31T15:45:41","date_gmt":"2026-07-31T15:45:41","guid":{"rendered":"https:\/\/onemedchronicle.com\/?p=414"},"modified":"2026-07-31T15:45:41","modified_gmt":"2026-07-31T15:45:41","slug":"glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices","status":"publish","type":"post","link":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/","title":{"rendered":"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">For years, GLP-1 medications meant one thing to most people: expensive injections for weight loss that insurance would not cover. That picture has changed significantly in 2026. Medicare is covering these drugs for weight management for the first time. A daily pill is now available. And prices have dropped to levels that were unthinkable two years ago.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Here is a clear breakdown of what changed, what it means for patients, and what practice owners need to do about it.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What GLP-1 Medications Actually Do<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">GLP-1 is a hormone your body already makes after eating. It tells the pancreas to release insulin, slows digestion, and reduces appetite. GLP-1 medications replicate that signal.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The practical result: better blood sugar control and meaningful weight loss.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These drugs were first approved for type 2 diabetes in 2005. Their applications have expanded significantly since then. Doctors now use them for cardiovascular risk reduction, chronic kidney disease, obstructive sleep apnea, and a liver condition called MASH. Research into effects on neurodegenerative conditions is ongoing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The brands most people recognize are Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound, made by Novo Nordisk and Eli Lilly.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">How Big Is This Market?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The scale of GLP-1 adoption in the US is huge. You can go through the figures below to get a fair idea:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.statista.com\/chart\/35919\/key-figures-usage-and-opinion-glp-1-medication-weight-loss-drugs-in-the-united-states\/\">About 1 in 8 US adults has used a GLP-1 drug<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.jpmorgan.com\/insights\/global-research\/current-events\/obesity-drugs\">Around 10 million Americans are currently on one, with J.P. Morgan projecting users could reach 25 to 30 million by 2030<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.ama-assn.org\/public-health\/behavioral-health\/spending-glp-1s-has-grown-dramatically-here-are-details\">US spending on GLP-1s grew more than 500% between 2018 and 2023<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This is no longer a specialty medication. It is a population-level shift affecting federal budgets, insurer decisions, and how chronic disease gets managed.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">The Changes to GLP-1 Access in 2026<\/h3>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/media.licdn.com\/dms\/image\/v2\/D5612AQHZGW1igt47sw\/article-inline_image-shrink_1000_1488\/B56Z6PXErmGsAI-\/0\/1780521651272?e=1787184000&amp;v=beta&amp;t=7JKo7_q7nahBsGxeiO4ysL6cEd2lg5JyZyk9bbHopxM\" alt=\"Article content\"\/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Medicare Is Now Covering GLP-1s for Weight Loss<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Federal law previously blocked Medicare from covering weight-loss drugs. That changed in November 2025 when federal officials reached agreements with Novo Nordisk and Eli Lilly to lower prices and expand access.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.cms.gov\/newsroom\/press-releases\/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries\">The Medicare GLP-1 Bridge<\/a> runs July 1, 2026, through December 31, 2027.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Eligible Part D members pay $50 a month for a covered GLP-1 prescribed for weight management<\/li>\n\n\n\n<li>Claims and prior authorization go through a central processor, not the patient&#8217;s regular Part D plan<\/li>\n\n\n\n<li>The $50 copay does not count toward the Part D deductible or annual out-of-pocket cap<\/li>\n\n\n\n<li>Patients already on a GLP-1 through Part D for diabetes, cardiovascular risk, sleep apnea, or MASH stay on their existing path<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Eligibility depends on BMI thresholds and conditions such as high blood pressure, heart failure, chronic kidney disease, prediabetes, or a history of cardiovascular disease.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Important note:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Coverage is not universal. State Medicaid decisions vary. Pennsylvania dropped weight-loss GLP-1 coverage starting in January 2026. The Bridge is a real step forward with real limits attached.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.cms.gov\/newsroom\/press-releases\/cms-launches-voluntary-model-expand-access-life-changing-medicines-promote-healthier-living\">A longer-term program, the BALANCE Model, launches in 2027.<\/a> It allows state Medicaid programs and Part D sponsors to cover GLP-1s for weight management under negotiated terms.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">There Is Now a GLP-1 Pill<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">On April 1, 2026, the <a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill\">FDA approved orforglipron (Foundayo)<\/a> from Eli Lilly. It is the first oral GLP-1 for chronic weight management that comes without the restrictions older oral versions carried.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">What makes it different:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Once daily, any time of day<\/li>\n\n\n\n<li>No empty stomach requirement<\/li>\n\n\n\n<li>No waiting period before eating or drinking<\/li>\n\n\n\n<li>No refrigeration needed<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In clinical trials, the highest dose produced <a href=\"https:\/\/www.ajmc.com\/view\/fda-approves-lilly-s-oral-glp-1-orforglipron-for-obesity\">an average weight loss of around 11 percent over 72 weeks<\/a> in adults without diabetes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Safety note:<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">It carries a boxed warning for thyroid C-cell tumor risk. It is not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2. The most common side effects are gastrointestinal.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Removing the injection requirement is a bigger deal than it sounds. Needle aversion and refrigeration kept many eligible patients from starting treatment. That barrier is now gone, which means the patient pool expands again.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Key Takeaways for Patients<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>If you are on Medicare, <a href=\"https:\/\/www.cms.gov\/medicare\/coverage\/prescription-drug-coverage\/medicare-glp-1-bridge\/information-medicare-beneficiaries\">ask your provider whether your BMI and health history meet the eligibility criteria.<\/a> The $50 monthly copay kicks in July 1, 2026.<\/li>\n\n\n\n<li>If needle aversion has been a barrier, <a href=\"https:\/\/www.pharmacytimes.com\/view\/fda-approves-orforglipron-first-glp-1-pill-without-time-food-or-water-restrictions\">Foundayo is now an option.<\/a> Your provider can assess whether it is appropriate for you.<\/li>\n\n\n\n<li>The shortage that made them a tolerated option has ended. They are not FDA-approved and are generally not covered. Work with a licensed prescriber and a verified pharmacy.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">What Does This Mean for Healthcare Providers?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Expanded coverage means more GLP-1 prescriptions flowing through your practice. That means more prior authorizations, more renewals, and more denial management. The billing complexity is not going down.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.ajmc.com\/view\/reducing-glp-1-prior-authorization-friction-a-managed-care-playbook\"><strong>Most GLP-1 denials are documentation problems, not coverage problems.<\/strong><\/a> Payers want BMI history, step therapy evidence where required, and qualifying comorbidities documented in full. Build a repeatable documentation packet and use it consistently.<\/li>\n\n\n\n<li>From July 1, 2026,<strong> <a href=\"https:\/\/www.cms.gov\/medicare\/coverage\/prescription-drug-coverage\/medicare-glp-1-bridge\/information-providers\">Bridge prescriptions route to a central processor<\/a><\/strong> with a specific BIN and PCN, not the patient&#8217;s Part D plan. Providers may need to attest to a patient&#8217;s BMI at the time therapy began, even if that was years earlier. Set up a process to capture and store that history now.<\/li>\n\n\n\n<li>The shortage that created legal space for compounded semaglutide is over. The FDA has restricted compounding.<strong> <a href=\"https:\/\/ldi.upenn.edu\/our-work\/research-updates\/patients-face-new-barriers-for-glp-1-drugs-like-wegovy-and-ozempic\/\">Billing compounded formulations to insurers now risks automatic denials and fraud and abuse scrutiny.<\/a><\/strong> Audit your billing if this applies to your practice.<\/li>\n\n\n\n<li><a href=\"https:\/\/www.amcp.org\/regulatory-newsbreak-cms-releases-frequently-asked-questions-medicare-glp-1-bridge\"><strong>CMS-0057-F, the prior authorization final rule, took effect January 1, 2026.<\/strong><\/a> It pushes payers toward faster electronic processing and tighter audit trails. Clean documentation is a compliance requirement, not just a billing preference.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Managing GLP-1 billing in-house is becoming a full-time job. If your practice is buried in prior authorization backlogs, tangled up in Bridge claim routing, or losing revenue to denials you can&#8217;t keep up with, OneMed&#8217;s billing team is ready to help. We specialize in revenue cycle management, from documentation to claims routing to denial appeals.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Give us a call at <strong>(315) 366-8242<\/strong> or send us a note at <strong>partners@onemedbilling.com,<\/strong> and we&#8217;ll take it from there.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sources<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The following URLs could not be embedded as anchor text within the content but are referenced for the facts and figures used:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>NPR \u2014 Medicare Bridge coverage explainer: <a href=\"https:\/\/www.npr.org\/2026\/05\/06\/nx-s1-5812662\/medicare-bridge-glp1-drugs-copay\">https:\/\/www.npr.org\/2026\/05\/06\/nx-s1-5812662\/medicare-bridge-glp1-drugs-copay<\/a><\/li>\n\n\n\n<li>Qualigenix \u2014 Prior authorization burden in 2026: <a href=\"https:\/\/qualigenix.com\/drug-prior-authorization-2026\/\">https:\/\/qualigenix.com\/drug-prior-authorization-2026\/<\/a><\/li>\n\n\n\n<li>Grand View Research \u2014 GLP-1 global market size: <a href=\"https:\/\/www.grandviewresearch.com\/industry-analysis\/glp-1-receptor-agonist-market\">https:\/\/www.grandviewresearch.com\/industry-analysis\/glp-1-receptor-agonist-market<\/a><\/li>\n\n\n\n<li>CNBC \u2014 GLP-1 effects on food and restaurant demand: <a href=\"https:\/\/www.cnbc.com\/2026\/03\/21\/glp-1-diets-restaurants-protein-fiber-weight-loss-drugs.html\">https:\/\/www.cnbc.com\/2026\/03\/21\/glp-1-diets-restaurants-protein-fiber-weight-loss-drugs.html<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>For years, GLP-1 medications meant one thing to most people: expensive injections for weight loss that insurance would not cover. That picture has changed significantly in 2026. Medicare is covering these drugs for weight management for the first time. A daily pill is now available. And prices have dropped to levels that were unthinkable two [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":416,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-414","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices - Chronicle<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices - Chronicle\" \/>\n<meta property=\"og:description\" content=\"For years, GLP-1 medications meant one thing to most people: expensive injections for weight loss that insurance would not cover. That picture has changed significantly in 2026. Medicare is covering these drugs for weight management for the first time. A daily pill is now available. And prices have dropped to levels that were unthinkable two [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/\" \/>\n<meta property=\"og:site_name\" content=\"Chronicle\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-31T15:45:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026-1024x576.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"OneMed Chronicle\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"OneMed Chronicle\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/\"},\"author\":{\"name\":\"OneMed Chronicle\",\"@id\":\"https:\/\/onemedchronicle.com\/#\/schema\/person\/8314bd7d917b26de24aac43ae24304b7\"},\"headline\":\"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices\",\"datePublished\":\"2026-07-31T15:45:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/\"},\"wordCount\":1060,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/onemedchronicle.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/\",\"url\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/\",\"name\":\"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices - Chronicle\",\"isPartOf\":{\"@id\":\"https:\/\/onemedchronicle.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026.png\",\"datePublished\":\"2026-07-31T15:45:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#primaryimage\",\"url\":\"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026.png\",\"contentUrl\":\"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026.png\",\"width\":1920,\"height\":1080,\"caption\":\"GLP-1 Updates 2026\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/onemedchronicle.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/onemedchronicle.com\/#website\",\"url\":\"https:\/\/onemedchronicle.com\/\",\"name\":\"Chronicle\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/onemedchronicle.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/onemedchronicle.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/onemedchronicle.com\/#organization\",\"name\":\"Chronicle\",\"url\":\"https:\/\/onemedchronicle.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/onemedchronicle.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/cropped-om-chronicle-logo-1.png\",\"contentUrl\":\"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/cropped-om-chronicle-logo-1.png\",\"width\":1049,\"height\":430,\"caption\":\"Chronicle\"},\"image\":{\"@id\":\"https:\/\/onemedchronicle.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/onemedchronicle.com\/#\/schema\/person\/8314bd7d917b26de24aac43ae24304b7\",\"name\":\"OneMed Chronicle\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/onemedchronicle.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/05a752acef6cf89ef45a58c1bea64ed8ef76619590196242dc9507a2cb633b4f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/05a752acef6cf89ef45a58c1bea64ed8ef76619590196242dc9507a2cb633b4f?s=96&d=mm&r=g\",\"caption\":\"OneMed Chronicle\"},\"sameAs\":[\"https:\/\/onemedchronicle.com\/\"],\"url\":\"https:\/\/onemedchronicle.com\/index.php\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices - Chronicle","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/","og_locale":"en_US","og_type":"article","og_title":"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices - Chronicle","og_description":"For years, GLP-1 medications meant one thing to most people: expensive injections for weight loss that insurance would not cover. That picture has changed significantly in 2026. Medicare is covering these drugs for weight management for the first time. A daily pill is now available. And prices have dropped to levels that were unthinkable two [&hellip;]","og_url":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/","og_site_name":"Chronicle","article_published_time":"2026-07-31T15:45:41+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026-1024x576.png","type":"image\/png"}],"author":"OneMed Chronicle","twitter_card":"summary_large_image","twitter_misc":{"Written by":"OneMed Chronicle","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#article","isPartOf":{"@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/"},"author":{"name":"OneMed Chronicle","@id":"https:\/\/onemedchronicle.com\/#\/schema\/person\/8314bd7d917b26de24aac43ae24304b7"},"headline":"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices","datePublished":"2026-07-31T15:45:41+00:00","mainEntityOfPage":{"@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/"},"wordCount":1060,"commentCount":0,"publisher":{"@id":"https:\/\/onemedchronicle.com\/#organization"},"image":{"@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#primaryimage"},"thumbnailUrl":"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026.png","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/","url":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/","name":"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices - Chronicle","isPartOf":{"@id":"https:\/\/onemedchronicle.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#primaryimage"},"image":{"@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#primaryimage"},"thumbnailUrl":"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026.png","datePublished":"2026-07-31T15:45:41+00:00","breadcrumb":{"@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#primaryimage","url":"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026.png","contentUrl":"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/GLP-1-Medications-in-2026.png","width":1920,"height":1080,"caption":"GLP-1 Updates 2026"},{"@type":"BreadcrumbList","@id":"https:\/\/onemedchronicle.com\/index.php\/2026\/07\/31\/glp-1-updates-2026-new-coverage-a-new-pill-and-what-it-means-for-patients-and-practices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/onemedchronicle.com\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Updates 2026: New Coverage, a New Pill, and What It Means for Patients and Practices"}]},{"@type":"WebSite","@id":"https:\/\/onemedchronicle.com\/#website","url":"https:\/\/onemedchronicle.com\/","name":"Chronicle","description":"","publisher":{"@id":"https:\/\/onemedchronicle.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/onemedchronicle.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/onemedchronicle.com\/#organization","name":"Chronicle","url":"https:\/\/onemedchronicle.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/onemedchronicle.com\/#\/schema\/logo\/image\/","url":"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/cropped-om-chronicle-logo-1.png","contentUrl":"https:\/\/onemedchronicle.com\/wp-content\/uploads\/2026\/07\/cropped-om-chronicle-logo-1.png","width":1049,"height":430,"caption":"Chronicle"},"image":{"@id":"https:\/\/onemedchronicle.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/onemedchronicle.com\/#\/schema\/person\/8314bd7d917b26de24aac43ae24304b7","name":"OneMed Chronicle","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/onemedchronicle.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/05a752acef6cf89ef45a58c1bea64ed8ef76619590196242dc9507a2cb633b4f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/05a752acef6cf89ef45a58c1bea64ed8ef76619590196242dc9507a2cb633b4f?s=96&d=mm&r=g","caption":"OneMed Chronicle"},"sameAs":["https:\/\/onemedchronicle.com\/"],"url":"https:\/\/onemedchronicle.com\/index.php\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/posts\/414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/comments?post=414"}],"version-history":[{"count":1,"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/posts\/414\/revisions"}],"predecessor-version":[{"id":417,"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/posts\/414\/revisions\/417"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/media\/416"}],"wp:attachment":[{"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/media?parent=414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/categories?post=414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/onemedchronicle.com\/index.php\/wp-json\/wp\/v2\/tags?post=414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}